What should the Test and evaluation authority stop, start, accelerate, merge or defer across the portfolio connected to test evidence and trial design?
The test plan does not yet prove the decision that leaders need to make.
Answer block
What the page can settle.
Door
Portfolio prioritisation
Mapped to the Bid Evidence Pack route.
Buyer
Test and evaluation authority
2-star/director, SRO, transformation lead, prime programme director, national programme office
Fit
How Lansary reads it.
DEE structures evidence and uncertainty around test evidence and trial design into decision-ready options.
First step
Portfolio trade matrix, stop/start recommendations, dependency view
Sell as a portfolio-prioritisation engagement.
Start with named public records.
- https://www.nato.int/en/what-we-do/introduction-to-nato/defence-expenditures-and-natos-5-commitment
- https://www.gov.uk/government/publications/the-strategic-defence-review-2025-making-britain-safer-secure-at-home-strong-abroad
- https://www.gov.uk/government/publications/defence-industrial-strategy-2025-making-defence-an-engine-for-growth
This page is a routing surface. The private Evidence Pack tests the named subject, dates, source boundary and decision consequence.